Abbott Laboratories Stock Forecast for 2023 - 2025 - 2030

Updated on 12/06/2023

Stock Rating
10
Price Target
$115.30
Consensus
Outperform
Upside
9.87%
Analysts
15
Stock Rating
10
Upside
9.87%
Analysts
15
Price Target
$115.30

Abbott Laboratories Stock Forecast and Price Target

Abbott Laboratories's stock price reaches the average target of $115.30 by 2024 as expected recently by fiveteen notable experts, there would be a potential upside of approximately 9.87% from the last closing price in December, 2023. This possible increase is based on a high estimate of $133.00 and a low estimate of $100.00. If you are interested in ABT stock, it is important to also consider its competitors.

$115.30

9.87% Upside

Outperform
Outperform

Abbott Laboratories Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Price has grown by 64.81%, rising from $80.84 to $133.23. For the following year, the 22 analysts predict that Abbott Laboratories's Fair Value will drop by 6.37%, reaching $124.75. Over the next eight years, experts predict that Abbott Laboratories's Fair Value will grow at a rate of 25.82%.

2023 Fair Value Forecast
$124.75
2024 Fair Value Forecast
$137.97
2025 Fair Value Forecast
$152.20
2026 Fair Value Forecast
$165.92
2027 Fair Value Forecast
$170.16
2028 Fair Value Forecast
$176.90
2029 Fair Value Forecast
$168.30
2030 Fair Value Forecast
$167.63
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ISRG Stock Forecast Intuitive Surgical Inc Outperform 15
$310.26 Buy/Sell $360.83 3.95%
BSX Stock Forecast Boston Scientific Corp Outperform 11
$54.82 Buy/Sell $60.80 9.45%
DXCM Stock Forecast DexCom Inc Buy 16
$117.94 Buy/Sell $125.98 5.99%
RMD Stock Forecast ResMed Inc Outperform 17
$164.00 Buy/Sell $220.76 6.10%
VAR Stock Forecast Varian Medical Systems - 16
$176.53 Buy/Sell $177.67 -100.00%

Abbott Laboratories Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Revenue has grown by 36.83%, rising from $31.90B to $43.65B. For the following year, the 23 analysts predict that Abbott Laboratories's Revenue will drop by 5.19%, reaching $41.39B. Over the next eight years, experts predict that Abbott Laboratories's Revenue will grow at a rate of 17.32%.

2023 Rev Forecast
$41.39B
2024 Rev Forecast
$44.20B
2025 Rev Forecast
$46.58B
2026 Rev Forecast
$49.65B
2027 Rev Forecast
$52.10B
2028 Rev Forecast
$54.81B
2029 Rev Forecast
$51.92B
2030 Rev Forecast
$51.21B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PODD Stock Forecast Insulet Outperform 15
$189.30 Buy/Sell $222.05 22.56%
LVGO Stock Forecast Livongo Health - 0
$0.00 Buy/Sell $0.00 0.00%
SWAV Stock Forecast Shockwave Medical Outperform 4
$172.53 Buy/Sell $0.00 36.79%

Abbott Laboratories Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Dividend per Share has grown, rising from $1.32 to $1.92 – a growth of 45.45%. In the next year, analysts believe that Dividend per Share will reach $1.96 – an increase of 2.08%. For the next eight years, the forecast is for Dividend per Share to grow by 32.24%.

2023 DPS Forecast
$1.96
2024 DPS Forecast
$2.11
2025 DPS Forecast
$2.53
2026 DPS Forecast
$2.78
2027 DPS Forecast
$2.45
2028 DPS Forecast
$2.35
2029 DPS Forecast
$2.42
2030 DPS Forecast
$2.54
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MASI Stock Forecast Masimo Outperform 14
$103.62 Buy/Sell $92.00 -17.00%
INSP Stock Forecast Inspire Medical Systems Outperform 6
$151.74 Buy/Sell $0.00 41.69%
CMD Stock Forecast Cantel Medical LLC - 17
$0.05 Buy/Sell $85.00 -100.00%

Abbott Laboratories Free Cash Flow Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Free Cash Flow has seen impressive growth In the last three years, rising from $4.50B to $7.70B – a growth of 71.10%. In the next year, analysts believe that Free Cash Flow will reach $8.56B – an increase of 11.26%. For the next eight years, the forecast is for Free Cash Flow to grow by 42.51%.

2023 FCF Forecast
$8.56B
2024 FCF Forecast
$9.04B
2025 FCF Forecast
$9.48B
2026 FCF Forecast
$9.58B
2027 FCF Forecast
$13.70B
2028 FCF Forecast
$12.07B
2029 FCF Forecast
$11.36B
2030 FCF Forecast
$10.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CNMD Stock Forecast CONMED Outperform 16
$108.35 Buy/Sell $123.38 13.06%
ITGR Stock Forecast Integer Holdings Outperform 16
$86.50 Buy/Sell $95.00 4.05%
AXNX Stock Forecast Axonics Outperform 7
$57.35 Buy/Sell $0.00 20.31%

Abbott Laboratories Net Income Forecast for 2023 - 2025 - 2030

Abbott Laboratories's Net Income has grown In the last three years, rising from $3.69B to $6.93B – a growth of 88.04%. In the next year, analysts believe that Net Income will reach $8.79B – an increase of 26.80%. For the next eight years, experts predict that Abbott Laboratories's Net Income will grow at a rate of 68.68%.

2023 NI Forecast
$8.79B
2024 NI Forecast
$9.75B
2025 NI Forecast
$10.69B
2026 NI Forecast
$11.74B
2027 NI Forecast
$12.03B
2028 NI Forecast
$12.17B
2029 NI Forecast
$11.66B
2030 NI Forecast
$11.69B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IRTC Stock Forecast iRhythm Technologies Outperform 11
$84.95 Buy/Sell $0.00 28.90%
TMDX Stock Forecast TransMedics Group Buy 8
$73.94 Buy/Sell $0.00 8.20%
GNMK Stock Forecast GenMark Diagnostics - 2
$0.00 Buy/Sell $24.05 0.00%

Abbott Laboratories EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EBITDA has grown by 55.75%, rising from $7.77B to $12.10B. For the next year, 11 analysts project Abbott Laboratories's EBITDA to drop by 1.35%, reaching $11.94B. Over the next eight years, experts believe that Abbott Laboratories's EBITDA will grow at a rate of 7.17%.

2023 EBITDA Forecast
$11.94B
2024 EBITDA Forecast
$13.15B
2025 EBITDA Forecast
$12.29B
2026 EBITDA Forecast
$13.49B
2027 EBITDA Forecast
$12.71B
2028 EBITDA Forecast
$12.89B
2029 EBITDA Forecast
$12.71B
2030 EBITDA Forecast
$12.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TNDM Stock Forecast Tandem Diabetes Care Outperform 9
$22.23 Buy/Sell $28.33 -1.03%
NTUS Stock Forecast Natus Medical - 14
$32.96 Buy/Sell $36.00 -100.00%
QTRX Stock Forecast Quanterix Outperform 11
$23.20 Buy/Sell $38.25 44.40%

Abbott Laboratories EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EBIT has grown, moving from $4.76B to $8.84B – an increase of 85.75%. In the next year, analysts predict that EBIT will jump to $10.32B – up 16.79% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 52.67%.

2023 EBIT Forecast
$10.32B
2024 EBIT Forecast
$11.31B
2025 EBIT Forecast
$12.07B
2026 EBIT Forecast
$13.81B
2027 EBIT Forecast
$14.30B
2028 EBIT Forecast
$13.95B
2029 EBIT Forecast
$13.32B
2030 EBIT Forecast
$13.49B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SLNO Stock Forecast Soleno Therapeutics Buy 0
$34.06 Buy/Sell $6.00 23.31%
NVRO Stock Forecast Nevro Hold 6
$18.92 Buy/Sell $20.09 -10.15%
SOLY Stock Forecast Soliton - 4
$22.59 Buy/Sell $23.00 6.33%

Abbott Laboratories EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EPS has grown by 64.81%, rising from $3.24 to $5.34. For the following year, the 22 analysts predict that Abbott Laboratories's EPS will drop by 6.37%, reaching $5.00. Over the next eight years, experts predict that Abbott Laboratories's EPS will grow at a rate of 25.82%.

2023 EPS Forecast
$5.00
2024 EPS Forecast
$5.53
2025 EPS Forecast
$6.10
2026 EPS Forecast
$6.65
2027 EPS Forecast
$6.82
2028 EPS Forecast
$7.09
2029 EPS Forecast
$6.75
2030 EPS Forecast
$6.72
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CLPT Stock Forecast ClearPoint Neuro Buy 11
$6.58 Buy/Sell $0.00 51.98%
PLSE Stock Forecast Pulse Biosciences - 0
$9.01 Buy/Sell $37.00 -100.00%
SILK Stock Forecast Silk Road Medical, Inc Hold 7
$9.64 Buy/Sell $0.00 8.92%